References
- Aldhahi W., Hamdy O. (2003). Adipokines, inflammation, and the endothelium in diabetes. Curr. Diab. Rep., 3: 293-298.
- Antuna - Puente B., Feve B., Fellahi S., Bastard J.P. (2008). Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab., 34: 2-11.
- Baker A.R., Silva D.W., Quinn A.L., Harte D., Pagano R.S., Bonser S., Kumar P.G., Mc Ternan N.H. (2006). Human epicardial adipose tissue expressesapathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc. Diabetol., 13: 5-10.
- Bakker W., Eringa E.C., Sipkema P.,van Hinsbergh V.W. (2009). Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res., 335: 165-189.
- Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., Lazar M.A. (2004). Regulation of fasted blood glucose by resistin. Science, 303: 1195-1198.
- Brown J.E., Onyango D.J., Dunmore S.J. (2007). Resistin down-regulates insulin receptor expression, and modulates cell viability in rodent pancreatic beta-cells. FEBS Lett., 581: 3273-3276.
- Chu S.W., Ding K., Li Y., Pang C., Tang C. (2008). Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ. J., 72: 1249-1253.
- Dai M.H., Xia T., Chen X.D., Gan L., Feng S.Q., Qiu H., Peng Y., Yang Z.Q. (2006). Cloning and characterization of porcine resistin gene. Domest. Anim. Endocrinol., 30: 88-97.
- Fantuzzi G. (2005). Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol., 115: 911-919.
- Fu Y., Luo L., Luo N., Garvey W.T. (2006). Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutr. Metab. (Lond)., 19: 3-28.
- Gao J., Chang Chua C., Chen Z., Wang H., Xu X., Hamdy R., Mc Mullen J.R., Shioi T., Izumo S., Chua B. (2007). Resistin, an adipocytokine, offers protection against acute myocardial infarction. J. Mol. Cell Cardiol., 43: 601-609.
- Gletsu - Miller N., Hansen J.M., Jones D.P., Go Y.M., Torres W.E., Ziegler T.R., Lin E. (2009). Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring), 17: 439-446.
- Hara H., Lin Y.J., Zhu X., Tai H.C., Ezzelarab M., Balamurugan A.N., Bottino R., Houser S.L., Cooper D.K. (2008). Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas., 36: 31-38.
- Hung H.F., Wang B.W., Chang H., Shyu K.G. (2008). The molecular regulation of resistin expression in cultured vascular smooth muscle cells under hypoxia. J. Hypertens., 26: 2349-2360.
- Iacobellis G., Barbaro G. (2008). The double role of epicardial adipose tissue as pro- and antiinflammatory organ. Horm. Metab. Res., 40: 442-445.
- Iacobellis G., Leonetti F. (2005). Epicardial adipose tissue and insulin resistance in obese subjects. J. Clin. Endocrinol. Metab., 90: 6300-6302.
- Iacobellis G.F., Assael M.C., Ribaudo A., Zappaterreno G., Alessi U., Di Mar-io F., Leonetti F. (2003). Epicardial fat from echocardiography:anew method for visceral adipose tissue prediction. Obes. Res., 11: 304-310.
- Iacobellis G.,di Gioia C.R., Cotesta D., Petramala L., Travaglini C., De San-tis V., Vitale D., Tritapepe L., Letizia C. (2009). Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm. Metab. Res., 41: 227-231.
- Karlsson S., Ostlund B., Myrs én- Axcrona U., Sundler F., Ahrén B. (2001). Beta cell adaptation to the dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness. Pancreas., 22: 148-156.
- Karmazyn M., Purdham D.M., Rajapurohitam V., Zeidan A. (2008). Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc. Res., 79: 279-286.
- Kawashima J., Tsuruzoe K., Motoshima H., Shirakami A., Sakai K., Hirashi-ma Y., Toyonaga T., Araki E. (2003). Insulin down-regulates resistin m RNAthrough the synthesis of protein(s) that could accelerate the degradation of resistin m RNAin 3T3-L1 adipocytes. Diabetologia, 46: 231-240.
- Kim M., Oh J.K., Sakata S., Liang I., Park W., Hajjar R.J., Lebeche D. (2008). Role of resistin in cardiac contractility and hypertrophy. J. Mol. Cell Cardiol., 45: 270-280.
- Korah T.E., Ibrahim H.H., Badr E.A., El Shafie M.K. (2011). Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. Postgrad. Med. J., 87: 463-467.
- Kremen J.M., Dolinkova J., Krajickova J., Blaha K., Anderlova Z., Lacinova D., Haluzikova L., Bosanska M., Vokurka S., Svacina M., Haluzik M. (2006). Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J. Clin. Endocrinol. Metab., 91: 4620-4627.
- Langheim S., Dreas L., Veschini L., Maisano F., Foglieni C., Ferrarello S., Sin-gara G., Zingone B., Alfieri O., Ferrero E., Maseri A., Ruotolo G. (2010). Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am. J. Physiol. Heart Circ. Physiol., 298: 746-753.
- Lin Y., Rajala M.W., Berger J.P., Moller D.E., Barzilai N., Scherer P.E. (2001). Hyperglycemia- induced production of acute phase reactants in adipose tissue. J. Biol. Chem., 276: 42077-42083.
- Mariappan N., Elks C.M., Sriramula S., Guggilam A., Liu Z., Borkhsenious O., Francis J. (2010). NF-kappa B-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type IIdiabetes. Cardiovasc. Res., 85: 473-483.
- Mars M.,de Graaf C.,de Groot L.C., Kok F.J. (2005). Decreases in fasting leptin and insulin concentrations after acute energy restriction and subsequent compensation in food intake. Am. J. Clin. Nutr., 81: 570-577.
- Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., Sarov- - Blat L., O ’ Brien S., Keiper E.A., Johnson A.G., Martin J., Goldstein B.J., Shi Y. (2003). Human epicardial adipose tissue isasource of inflammatory mediators. Circulation, 108: 2460-2466.
- Meugnier E., Faraj M., Rome S., Beauregard G., Michaut A., Pelloux V., Chias-son J.L., Laville M., Clement K., Vidal H., Rabasa - Lhoret R. (2007). Acute hyperglycemia inducesaglobal downregulation of gene expression in adipose tissue and skeletal muscle of healthy subjects. Diabetes, 56: 992-999.
- Miles P.D., Romeo O.M., Higo K., Cohen A., Rafaat K., Olefsky J.M. (1997). TNFalpha induced insulin resistance in vivo and its prevention by troglitazone. Diabetes, 46: 1678-1683.
- Mu H., Ohashi R., Yan S., Chai H., Yang H., Lin P., Yao Q., Chen C. (2006). Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc. Res., 70: 146-157.
- Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., La -zar M.A. (2004). Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes, 53: 1937-1941.
- Sakoda H., Ogihara T., Anai M., Funaki M., Inukai K., Katagiri H., Fukushi-ma Y., Onishi Y., Ono H., Fujishiro M., Kikuchi M., Oka Y., Asano T. (2000). Dexamethasone- induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes, 49: 1700-1708.
- Sasayama D., Hori H., Nakamura S., Yamamoto N., Hattori K., Teraishi T., Ota M., Kunugi H. (2014). Increased protein and m RNAexpression of resistin after dexamethasone administration. Horm. Metab. Res., DOI: 10.1055/s-0034-1383651.
- Sato N., Kobayashi K., Inoguchi T., Sonoda N., Imamura M., Sekiguchi N., Na -kashima N., Schook L.B., Beever J.E., Roger J., Humphray S., Archibald A., Chardon P., Milan D., Rohrer G., Eversole K. (2005). Swine Genome Sequencing Consortium (SGSC):astrategic roadmap for sequencing the pig genome. Comp. Funct. Genom., 6: 251-255.
- Sheng C.H., Di J., Jin Y., Zhang Y.C., Wu M., Sun Y., Zhang G.Z. (2008). Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine, 33: 135-143.
- Shojima N., Sakoda H., Ogihara T., Fujishiro M., Katagiri H., Anai M., Onis -hi Y., Ono H., Inukai K., Abe M., Fukushima Y., Kikuchi M., Oka Y., Asano T. (2002). Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes, 51: 1737-1744.
- Stan D., Calin M., Manduteanu I., Pirvulescu M., Gan A.M., Butoi E.D., Simion V., Simionescu M. (2011). High glucose induces enhanced expression of resistin in human U937 monocyte-like cell line by MAPK- and NF-k B-dependent mechanisms; the modulating effect of insulin. Cell Tissue Res., 343: 379-387.
- Stelmanska E., Kmiec Z., Swierczynski J. (2012). The gender- and fat depot-specific regulation of leptin, resistin and adiponectin genes expression by progesterone in rat. J. Steroid. Biochem. Mol. Biol., 132: 160-167.
- Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. (2001). The hormone resistin links obesity to diabetes. Nature, 409: 307-312.
- van Raalte D.H., Diamant M. (2014). Steroid diabetes: from mechanism to treatment? Neth. J. Med., 72: 62-72.
- Yki- J ärvinen H. (2004). Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue. Eur. J. Clin. Invest., 34: 410-416.